|   | gener 2016 | Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer | López Siles, Mireia
			
			;					Martínez Medina, Margarita
			
			;					Surís Valls, Romà
			
			;					Aldeguer i Manté, Xavier
			
			;					Sàbat Mir, Míriam
			
			;					Duncan, Sylvia H.
			
			;					Flint, Harry J.
			
			;					Garcia-Gil, L. J. | 
	
	
		|   | juny 2018 | Desmetilació genòmica com a biomarcador de predisposició a càncers múltiples | Navarro Jiménez, Maria | 
	
	
		|   |  | Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients | Cubiella, Joaquín
			
			;					Vega, Pablo
			
			;					Salve, María
			
			;					Díaz Ondina, Marta
			
			;					Alves, Maria Teresa
			
			;					Quintero, Enrique
			
			;					Álvarez Sánchez, Victoria
			
			;					Fernández Bañares, Fernándo
			
			;					Boadas, Jaume
			
			;					Campo, Rafel
			
			;					Bujanda, Luis
			
			;					Clofent, Joan
			
			;					Ferrandez, Ángel
			
			;					Torrealba, Leyanira
			
			;					Piñol Sánchez, Virgínia
			
			;					Rodríguez Alcalde, Daniel
			
			;					Hernández, Vicent
			
			;					Fernández Seara, Javier | 
	
	
		|   |  | Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients | Cubiella, Joaquín
			
			;					Vega, Pablo
			
			;					Salve, María
			
			;					Díaz Ondina, Marta
			
			;					Alves, Maria Teresa
			
			;					Quintero, Enrique
			
			;					Álvarez Sánchez, Victoria
			
			;					Fernández Bañares, Fernándo
			
			;					Boadas, Jaume
			
			;					Campo, Rafel
			
			;					Bujanda, Luis
			
			;					Clofent, Joan
			
			;					Ferrandez, Ángel
			
			;					Torrealba, Leyanira
			
			;					Piñol Sánchez, Virgínia
			
			;					Rodríguez Alcalde, Daniel
			
			;					Hernández, Vicent
			
			;					Fernández Seara, Javier | 
	
	
		|   | 1 juny 2018 | Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients |  | 
	
	
		|   | 5 juny 2018 | Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients | Cubiella, Joaquín
			
			;					Vega, Pablo
			
			;					Salve, María
			
			;					Díaz Ondina, Marta
			
			;					Alves, Maria Teresa
			
			;					Quintero, Enrique
			
			;					Álvarez Sánchez, Victoria
			
			;					Fernández Bañares, Fernándo
			
			;					Boadas, Jaume
			
			;					Campo, Rafel
			
			;					Bujanda, Luis
			
			;					Clofent, Joan
			
			;					Ferrandez, Ángel
			
			;					Torrealba, Leyanira
			
			;					Piñol Sánchez, Virgínia
			
			;					Rodríguez Alcalde, Daniel
			
			;					Hernández, Vicent
			
			;					Fernández Seara, Javier | 
	
	
		|   | 31 agost 2016 | Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients | Cubiella, Joaquín
			
			;					Vega, Pablo
			
			;					Salve, María
			
			;					Díaz Ondina, Marta
			
			;					Alves, Maria Teresa
			
			;					Quintero, Enrique
			
			;					Álvarez Sánchez, Victoria
			
			;					Fernández Bañares, Fernándo
			
			;					Boadas, Jaume
			
			;					Campo, Rafel
			
			;					Bujanda, Luis
			
			;					Clofent, Juan
			
			;					Ferrandez, Ángel
			
			;					Torrealba, Leyanira
			
			;					Piñol Sánchez, Virgínia
			
			;					Rodríguez Alcalde, Daniel
			
			;					Hernández, Vicent
			
			;					Fernández Seara, Javier | 
	
	
		|   | 2018 | La dieta com a prevenció primària pel desenvolupament del càncer colorectal: revisió bibliogràfica | Soler Renart, Anna | 
	
	
		|   |  | Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models | Oliveras Ferrarós, Cristina
			
			;					Vázquez Martín, Alejandro
			
			;					Queralt, Bernardo
			
			;					Adrados, Manuel
			
			;					Ortiz, Rosa
			
			;					Cufí González, Sílvia
			
			;					Hernández Yagüe, Xavier
			
			;					Guardeño, Raquel
			
			;					Báez, Luciana
			
			;					Martin Castillo, Begoña
			
			;					Pérez Martínez, Maria Carmen
			
			;					López Bonet, Eugeni
			
			;					Llorens Duran, Rafael de
			
			;					Bernadó, Luis
			
			;					Brunet i Vidal, Joan
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   |  | Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models | Oliveras Ferrarós, Cristina
			
			;					Vázquez Martín, Alejandro
			
			;					Queralt, Bernardo
			
			;					Adrados, Manuel
			
			;					Ortiz, Rosa
			
			;					Cufí González, Sílvia
			
			;					Hernández Yagüe, Xavier
			
			;					Guardeño, Raquel
			
			;					Báez, Luciana
			
			;					Martin Castillo, Begoña
			
			;					Pérez Martínez, Maria Carmen
			
			;					López Bonet, Eugeni
			
			;					Llorens Duran, Rafael de
			
			;					Bernadó, Luis
			
			;					Brunet i Vidal, Joan
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   | 1 juny 2018 | Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models |  | 
	
	
		|   | 5 juny 2018 | Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models | Oliveras Ferrarós, Cristina
			
			;					Vázquez Martín, Alejandro
			
			;					Queralt, Bernardo
			
			;					Adrados, Manuel
			
			;					Ortiz, Rosa
			
			;					Cufí González, Sílvia
			
			;					Hernández Yagüe, Xavier
			
			;					Guardeño, Raquel
			
			;					Báez, Luciana
			
			;					Martin Castillo, Begoña
			
			;					Pérez Martínez, Maria Carmen
			
			;					López Bonet, Eugeni
			
			;					Llorens Duran, Rafael de
			
			;					Bernadó, Luis
			
			;					Brunet i Vidal, Joan
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   | 2011 | Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models | Oliveras Ferrarós, Cristina
			
			;					Vázquez Martín, Alejandro
			
			;					Queralt, Bernardo
			
			;					Adrados, Manuel
			
			;					Ortiz Duran, Maria Rosa
			
			;					Cufí González, Sílvia
			
			;					Hernández Yagüe, Xavier
			
			;					Guardeño, Raquel
			
			;					Báez, Luciana
			
			;					Martin Castillo, Begoña
			
			;					Pérez Martínez, Maria Carmen
			
			;					López Bonet, Eugeni
			
			;					Llorens Duran, Rafael de
			
			;					Bernadó, Luis
			
			;					Brunet i Vidal, Joan
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   |  | Intestinal microbiota in the adenoma progression to colorectal cancer: a cross-sectional study | Brujats Rubirola, Anna | 
	
	
		|   | novembre 2014 | Intestinal microbiota in the adenoma progression to colorectal cancer: a cross-sectional study | Brujats Rubirola, Anna | 
	
	
		|   |  | Intestinal microbiota in the adenoma progression to colorectal cancer: a cross-sectional study | Brujats Rubirola, Anna | 
	
	
		|   | 8 febrer 2016 | Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis | Mur, Pilar
			
			;					Sánchez Cuartielles, Elena
			
			;					Aussó Trias, Susanna
			
			;					Aiza, Gemma
			
			;					Valdés Mas, Rafael
			
			;					Pineda, Marta
			
			;					Navarro, Matilde
			
			;					Brunet i Vidal, Joan
			
			;					Urioste, Miguel
			
			;					Lázaro, Conxi
			
			;					Moreno, Victor
			
			;					Capellá, Gabriel
			
			;					Puente, Xose S.
			
			;					Valle, Laura | 
	
	
		|   | 12 setembre 2016 | Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer | Queralt, Bernardo
			
			;					Cuyàs, Elisabet
			
			;					Bosch Barrera, Joaquim
			
			;					Massaguer i Vall-llovera, Anna
			
			;					Llorens Duran, Rafael de
			
			;					Martin Castillo, Begoña
			
			;					Brunet i Vidal, Joan
			
			;					Salazar, Ramon
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   |  | Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer | Queralt, Bernardo
			
			;					Cuyàs, Elisabet
			
			;					Bosch Barrera, Joaquim
			
			;					Massaguer i Vall-llovera, Anna
			
			;					Llorens Duran, Rafael de
			
			;					Martin Castillo, Begoña
			
			;					Brunet i Vidal, Joan
			
			;					Salazar, Ramon
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   |  | Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer | Queralt, Bernardo
			
			;					Cuyàs, Elisabet
			
			;					Bosch Barrera, Joaquim
			
			;					Massaguer i Vall-llovera, Anna
			
			;					Llorens Duran, Rafael de
			
			;					Martin Castillo, Begoña
			
			;					Brunet i Vidal, Joan
			
			;					Salazar, Ramon
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   | 1 juny 2018 | Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |  | 
	
	
		|   | 5 juny 2018 | Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer | Queralt, Bernardo
			
			;					Cuyàs, Elisabet
			
			;					Bosch Barrera, Joaquim
			
			;					Massaguer i Vall-llovera, Anna
			
			;					Llorens Duran, Rafael de
			
			;					Martin Castillo, Begoña
			
			;					Brunet i Vidal, Joan
			
			;					Salazar, Ramon
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   | 2012 | Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment | Oliveras Ferrarós, Cristina
			
			;					Massaguer i Vall-llovera, Anna
			
			;					Vázquez Martín, Alejandro
			
			;					Carrion Salip, Dolors
			
			;					Queralt, Bernardo
			
			;					Cufí González, Sílvia
			
			;					Martin Castillo, Begoña
			
			;					Bosch Barrera, Joaquim
			
			;					Brunet i Vidal, Joan
			
			;					Llorens Duran, Rafael de
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   |  | Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment | Oliveras Ferrarós, Cristina
			
			;					Massaguer i Vall-llovera, Anna
			
			;					Vázquez Martín, Alejandro
			
			;					Carrion Salip, Dolors
			
			;					Queralt, Bernardo
			
			;					Cufí González, Sílvia
			
			;					Martin Castillo, Begoña
			
			;					Bosch Barrera, Joaquim
			
			;					Brunet i Vidal, Joan
			
			;					Llorens Duran, Rafael de
			
			;					Menéndez Menéndez, Javier Abel | 
	
	
		|   |  | Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment | Oliveras Ferrarós, Cristina
			
			;					Massaguer i Vall-llovera, Anna
			
			;					Vázquez Martín, Alejandro
			
			;					Carrion Salip, Dolors
			
			;					Queralt, Bernardo
			
			;					Cufí González, Sílvia
			
			;					Martin Castillo, Begoña
			
			;					Bosch Barrera, Joaquim
			
			;					Brunet i Vidal, Joan
			
			;					Llorens Duran, Rafael de
			
			;					Menéndez Menéndez, Javier Abel |